Drug profile · INN
ropinirole hydrochloride
ROPINIROLE HYDROCHLORIDE
ropinirole hydrochloride (ROPINIROLE HYDROCHLORIDE) is a d2-like dopamine receptor agonist. Associated with ELITE PHARMACEUTICALS INC /NV/. Route of administration: oral. Current US regulatory status: approved.
Drug details — ropinirole hydrochloride
- US status
- approved
- Class
- —
- Route
- ORAL
- Patents
- 0
- Programs
- 1
- Data quality
- 0.89
Quick answer
ropinirole hydrochloride (ROPINIROLE HYDROCHLORIDE) is a d2-like dopamine receptor agonist. Associated with ELITE PHARMACEUTICALS INC /NV/. Route of administration: oral. Current US regulatory status: approved.
Key facts
Mechanism of action
D2-like dopamine receptor agonist
Primary target: D2-like dopamine receptor
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Pipeline programs
Related & competitor drugs
Frequently asked questions
What is ropinirole hydrochloride?
ropinirole hydrochloride (ROPINIROLE HYDROCHLORIDE) is a d2-like dopamine receptor agonist. Associated with ELITE PHARMACEUTICALS INC /NV/. Route of administration: oral. Current US regulatory status: approved.
What is the brand name for ropinirole hydrochloride?
ROPINIROLE HYDROCHLORIDE is a marketed brand name for ropinirole hydrochloride. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of ropinirole hydrochloride?
ropinirole hydrochloride has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.